⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
CECP Summit 2026: Purpose Reignited
accessnewswire.com
C
AMGN
IBM
GOOG
MSFT
BAC
XOM
WFC
MET
JPM
GE
AMAT
EQIX
DIS
BIIB
REGN
ZTS
BBY
CSCO
ED
MA
PFE
LNC
INTC
NVDA
AMD
MU
DE
CAT
HON
BA
GEV
NEE
EXC
FISV
INTU
BNTX
MRK
SAN
BEN
STX
GOOGL
FIS
NIIMBL Announces 8 New Technology and Workforce Projects
prnewswire.com
AMGN
BMY
CSL
GSK
JNJ
PFE
WST
Sotyktu’s Psoriatic Arthritis Launch Builds Gradually in Month Two as Rheumatologists Continue to Take Measured Approach to TYK2 Adoption, According to Spherix Global Insights
globenewswire.com
BMY
ABBV
UCB
ALMS
PFE
Polymyositis Market Research Report 2026-2036: Competitive Landscape is Dominated by Major Players Such As Teva Pharmaceuticals, Gilead Sciences, Roche, AbbVie, and Pfizer
globenewswire.com
TEVA
GILD
ABBV
PFE
Legal-Bay Pre Settlement Funding Provides Financial Support for Plaintiffs in Depo-Provera Litigation
prnewswire.com
PFE
Kernicterus Market Research and Forecast Report 2026-2036 Featuring Pfizer, F.Hoffmann La Roche,. Merck, AbbVie, AsteraZeneca, Abbott Laboratories, Sanofi, GlaxoSmithKline, Grifols
globenewswire.com
PFE
ABBV
AMGN
ABT
GILD
Biosimilars Market to Reach USD 72.29 Billion by 2035 | MarketsandMarkets™
globenewswire.com
PFE
AMGN
Global Radiopharmaceuticals Market Set for Significant Expansion at a CAGR of ~10% by 2034 with Increasing Adoption of Targeted Radiotherapy | DelveInsight
prnewswire.com
LH
TH
GEHC
EL
AZN
AMGN
PFE
MRK
BMY
REGN
GILD
ABBV
SNY
XRAY
BRKR
FMI Reveals Bleeding Disorder Testing Market USD 117.1 Billion in 2026 to USD 234.6 Billion by 2036 Driven by Expanding Demand for Performance-Grade Diagnostic Solutions
accessnewswire.com
TMO
ABT
PFE
BAX
Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026
prnewswire.com
PFE